Aethon Therapeutics
New York, NY
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer-associated mutations.
aethontx.comCompany Details
Founded
- 2022
Employees
- Between 5 - 20 employees
Raised
- $30,000,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
Company Collections
These are collections Aethon Therapeutics is a part of. Click on the collection name to view similar companies.